Advertisement
Screener

VIATRIS INC. (VTRS) Other Comprehensive Income (Loss), Derivative, Excluded Component, Increase (Decrease), before Adjustments, Tax

2.8 / 5 stars · 68/120 Roast Me

VIATRIS INC. Other Comprehensive Income (Loss), Derivative, Excluded Component, Increase (Decrease), before Adjustments, Tax

VIATRIS INC. (VTRS) reported Other Comprehensive Income (Loss), Derivative, Excluded Component, Increase (Decrease), before Adjustments, Tax of $0 for the 12-month period ending 2022-12-31, per its 10-K filed 2023-02-27.

Discontinued › Expense Statement › Income Tax

us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsTax · last filed 2023-02-27

  • VIATRIS INC. other comprehensive income (loss), derivative, excluded component, increase (decrease), before adjustments, tax for fiscal 2022 was $0.00.
  • VIATRIS INC. other comprehensive income (loss), derivative, excluded component, increase (decrease), before adjustments, tax for fiscal 2021 was $0.00, a 100.00% decline from fiscal 2020.
  • VIATRIS INC. other comprehensive income (loss), derivative, excluded component, increase (decrease), before adjustments, tax for fiscal 2020 was $7.10M.
Period endOther Comprehensive Income (Loss), Derivative, Excluded Component, Increase (Decrease), before Adjustments, Tax 12 month
2022-12-31$0.00
10-K · filed 2023-02-27
2021-12-31$0.00
10-K · filed 2023-02-27
2020-12-31$7.10M
10-K · filed 2023-02-27

Similar stocks

Stock NameCountryMarket CapPE Ratio
UNITED THERAPEUTICS Corp (UTHR)United States$20.249B17.64
Royalty Pharma plc (RPRX)United States$22.628B
Jazz Pharmaceuticals plc (JAZZ)$15.333B16.07
Roivant Sciences Ltd. (ROIV)$26.105B-96.08
INSMED Inc (INSM)United States$26.566B-26.60
Summit Therapeutics Inc. (SMMT)United States$13.071B-13.21
BridgeBio Pharma, Inc. (BBIO)United States$12.947B-20.72
CORCEPT THERAPEUTICS INC (CORT)United States$12.804B169.10
BIOMARIN PHARMACEUTICAL INC (BMRN)United States$11.879B151.80
MADRIGAL PHARMACEUTICALS, INC. (MDGL)United States$11.859B-38.17